12,947 Shares in Astera Labs, Inc. $ALAB Bought by Independent Financial Group LLC

Independent Financial Group LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) in the first quarter, Holdings Channel.com reports. The firm acquired 12,947 shares of the company’s stock, valued at approximately $1,419,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ALAB. Atreides Management LP increased its stake in shares of Astera Labs by 2,496.6% during the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after purchasing an additional 1,549,144 shares in the last quarter. Amundi lifted its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership purchased a new position in Astera Labs in the 4th quarter valued at about $148,980,000. Goldman Sachs Group Inc. boosted its holdings in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the last quarter. Finally, State Street Corp boosted its holdings in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

ALAB opened at $303.62 on Monday. The firm has a market capitalization of $52.04 billion, a price-to-earnings ratio of 205.15, a price-to-earnings-growth ratio of 3.42 and a beta of 3.66. The company’s 50 day simple moving average is $349.32 and its two-hundred day simple moving average is $220.94. Astera Labs, Inc. has a 1-year low of $96.79 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the business earned $0.33 earnings per share. The business’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,676,845 shares of company stock valued at $444,928,806. Insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Royal Bank Of Canada increased their target price on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Susquehanna boosted their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, Rothschild & Co Redburn started coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $275.75.

Get Our Latest Stock Report on Astera Labs

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.